Skip to main content

Jiang Wenbin's Form 4 filing

Cytek Biosciences, Inc. (CTKB) · filed Aug 20, 2026

Accession no.
0001872873-26-000006
Filed
Aug 20, 2026, 4:35 PM ET
Trade date
Aug 18, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jiang WenbinCIK 0001872873Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2026Common StockMOption exerciseAcquired+11,781––5,488,984Direct
Aug 18, 2026Common StockFTax withholdingDisposed−2,869$4.67−$13,398.235,486,115Direct
Aug 18, 2026Common StockMOption exerciseAcquired+22,100––5,508,215Direct
Aug 18, 2026Common StockFTax withholdingDisposed−5,382$4.67−$25,133.945,502,833Direct
Aug 18, 2026Common StockMOption exerciseAcquired+29,002––5,531,835Direct
Aug 18, 2026Common StockFTax withholdingDisposed−7,062$4.67−$32,979.545,524,773Direct
Aug 18, 2026Common StockMOption exerciseAcquired+57,212––5,581,985Direct
Aug 18, 2026Common StockFTax withholdingDisposed−20,956$4.67−$97,864.525,561,029Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 18, 2026Common StockMOption exerciseDisposed−11,781$0.00$027,494Direct
Aug 18, 2026Common StockMOption exerciseDisposed−22,100$0.00$0139,973Direct
Aug 18, 2026Common StockMOption exerciseDisposed−29,002$0.00$0299,694Direct
Aug 18, 2026Common StockMOption exerciseDisposed−57,212$0.00$0820,054Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)